Oslo Cancer Cluster R&D Network meeting
The Oslo Cancer Cluster team are happy to invite you to an R&D Network on personalized cancer medicine – this time seen from the legal and ethical view, as well as touching upon the societal implications of personalized medicine and the investor perspective.
Main content
Time: Wednesday December 9th, kl 14.00-17.30
Venue: Kaare Norum aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation park, Ullernchausséen 64, Oslo
PLEASE SIGN UP BY DECEMBER 5thHERE
PROGRAM
14:00–14:30 Registration and coffee
14:30–14:45 Welcome and update
Ketil Widerberg, general manager Oslo Cancer Cluster
14:45–15:15 Norwegian Cancer Genomics Consortium – an update
Ola Myklebost, Norwegian Cancer Genomics Consortium
15:15–15:40 Oncoimmunity - design & guiding in personalized medicine
Richard Stratford, Oncoimmunity
15:40–16:00 Ethical and societal implications of personalized medicine
Sigrid Thoresen, senior advisor, The Norwegian Biotechnology Advisory Board
16:00–16:20 Legal regulation of personalized cancer medicine
Heidi Beate Bentzen , PhD Candidate, Centre for Medical Ethics and The Norwegian Research Center for Computers and Law, University of Oslo
16:20–16:40 Personalized cancer medicine – the investor’s perspective
Johan Christenson, Partner, HealthCap
16:40 Networking with light refreshments
We look forward to an interesting meeting!
Any questions, please contact mbl@oslocancercluster.no